Get Real Time Here
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Dynavax Technologies Stock (NASDAQ:DVAX), Quotes and News Summary
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | 0.030 | 0.1200 | ||||
| REV | 48.380M | 60.249M | 11.869M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
| 2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
| 2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
| 2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DVAX | Dynavax Technologies | -0.66% | 1.8B |
| IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
| RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
| ZNTL | Zentalis Pharma | -3.93% | 1.5B |
| MRTX | Mirati Therapeutics | 12.33% | 2.9B |
How do I buy Dynavax Technologies (DVAX) stock?
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Who are Dynavax Technologies's (DVAX) competitors?
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Dynavax Technologies (DVAX)?
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
Does Dynavax Technologies (DVAX) pay a dividend?
There is no dividend information for Dynavax Technologies.
When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Dynavax Technologies (DVAX) going to split?
There is no upcoming split for Dynavax Technologies.
What sector and industry does Dynavax Technologies (DVAX) operate in?
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ:DVAX), Quotes and News Summary
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | 0.030 | 0.1200 | ||||
| REV | 48.380M | 60.249M | 11.869M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
| 2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
| 2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
| 2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DVAX | Dynavax Technologies | -0.66% | 1.8B |
| IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
| RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
| ZNTL | Zentalis Pharma | -3.93% | 1.5B |
| MRTX | Mirati Therapeutics | 12.33% | 2.9B |
How do I buy Dynavax Technologies (DVAX) stock?
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Who are Dynavax Technologies's (DVAX) competitors?
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Dynavax Technologies (DVAX)?
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
Does Dynavax Technologies (DVAX) pay a dividend?
There is no dividend information for Dynavax Technologies.
When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Dynavax Technologies (DVAX) going to split?
There is no upcoming split for Dynavax Technologies.
What sector and industry does Dynavax Technologies (DVAX) operate in?
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ:DVAX), Quotes and News Summary
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | 0.030 | 0.1200 | ||||
| REV | 48.380M | 60.249M | 11.869M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
| 2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
| 2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
| 2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DVAX | Dynavax Technologies | -0.66% | 1.8B |
| IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
| RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
| ZNTL | Zentalis Pharma | -3.93% | 1.5B |
| MRTX | Mirati Therapeutics | 12.33% | 2.9B |
How do I buy Dynavax Technologies (DVAX) stock?
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Who are Dynavax Technologies's (DVAX) competitors?
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Dynavax Technologies (DVAX)?
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
Does Dynavax Technologies (DVAX) pay a dividend?
There is no dividend information for Dynavax Technologies.
When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Dynavax Technologies (DVAX) going to split?
There is no upcoming split for Dynavax Technologies.
What sector and industry does Dynavax Technologies (DVAX) operate in?
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ:DVAX), Quotes and News Summary
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | 0.030 | 0.1200 | ||||
| REV | 48.380M | 60.249M | 11.869M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
| 2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
| 2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
| 2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DVAX | Dynavax Technologies | -0.66% | 1.8B |
| IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
| RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
| ZNTL | Zentalis Pharma | -3.93% | 1.5B |
| MRTX | Mirati Therapeutics | 12.33% | 2.9B |
How do I buy Dynavax Technologies (DVAX) stock?
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Who are Dynavax Technologies's (DVAX) competitors?
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Dynavax Technologies (DVAX)?
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
Does Dynavax Technologies (DVAX) pay a dividend?
There is no dividend information for Dynavax Technologies.
When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Dynavax Technologies (DVAX) going to split?
There is no upcoming split for Dynavax Technologies.
What sector and industry does Dynavax Technologies (DVAX) operate in?
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ:DVAX), Quotes and News Summary
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | 0.030 | 0.1200 | ||||
| REV | 48.380M | 60.249M | 11.869M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
| 2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
| 2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
| 2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DVAX | Dynavax Technologies | -0.66% | 1.8B |
| IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
| RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
| ZNTL | Zentalis Pharma | -3.93% | 1.5B |
| MRTX | Mirati Therapeutics | 12.33% | 2.9B |
How do I buy Dynavax Technologies (DVAX) stock?
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Who are Dynavax Technologies's (DVAX) competitors?
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Dynavax Technologies (DVAX)?
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
Does Dynavax Technologies (DVAX) pay a dividend?
There is no dividend information for Dynavax Technologies.
When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Dynavax Technologies (DVAX) going to split?
There is no upcoming split for Dynavax Technologies.
What sector and industry does Dynavax Technologies (DVAX) operate in?
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ:DVAX), Quotes and News Summary
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | 0.030 | 0.1200 | ||||
| REV | 48.380M | 60.249M | 11.869M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
| 2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
| 2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
| 2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DVAX | Dynavax Technologies | -0.66% | 1.8B |
| IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
| RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
| ZNTL | Zentalis Pharma | -3.93% | 1.5B |
| MRTX | Mirati Therapeutics | 12.33% | 2.9B |
How do I buy Dynavax Technologies (DVAX) stock?
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Who are Dynavax Technologies's (DVAX) competitors?
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Dynavax Technologies (DVAX)?
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
Does Dynavax Technologies (DVAX) pay a dividend?
There is no dividend information for Dynavax Technologies.
When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Dynavax Technologies (DVAX) going to split?
There is no upcoming split for Dynavax Technologies.
What sector and industry does Dynavax Technologies (DVAX) operate in?
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ:DVAX), Quotes and News Summary
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | 0.030 | 0.1200 | ||||
| REV | 48.380M | 60.249M | 11.869M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
| 2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
| 2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
| 2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DVAX | Dynavax Technologies | -0.66% | 1.8B |
| IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
| RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
| ZNTL | Zentalis Pharma | -3.93% | 1.5B |
| MRTX | Mirati Therapeutics | 12.33% | 2.9B |
How do I buy Dynavax Technologies (DVAX) stock?
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Who are Dynavax Technologies's (DVAX) competitors?
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Dynavax Technologies (DVAX)?
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
Does Dynavax Technologies (DVAX) pay a dividend?
There is no dividend information for Dynavax Technologies.
When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Dynavax Technologies (DVAX) going to split?
There is no upcoming split for Dynavax Technologies.
What sector and industry does Dynavax Technologies (DVAX) operate in?
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ:DVAX), Quotes and News Summary
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | 0.030 | 0.1200 | ||||
| REV | 48.380M | 60.249M | 11.869M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
| 2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
| 2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
| 2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DVAX | Dynavax Technologies | -0.66% | 1.8B |
| IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
| RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
| ZNTL | Zentalis Pharma | -3.93% | 1.5B |
| MRTX | Mirati Therapeutics | 12.33% | 2.9B |
How do I buy Dynavax Technologies (DVAX) stock?
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Who are Dynavax Technologies's (DVAX) competitors?
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Dynavax Technologies (DVAX)?
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
Does Dynavax Technologies (DVAX) pay a dividend?
There is no dividend information for Dynavax Technologies.
When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Dynavax Technologies (DVAX) going to split?
There is no upcoming split for Dynavax Technologies.
What sector and industry does Dynavax Technologies (DVAX) operate in?
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dynavax Technologies Stock (NASDAQ:DVAX), Quotes and News Summary
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
| Open13.760 | Close13.640 |
| Vol / Avg.1.015M / 1.749M | Mkt Cap1.757B |
| Day Range13.570 - 13.850 | 52 Wk Range9.420 - 15.120 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | 0.030 | 0.1200 | ||||
| REV | 48.380M | 60.249M | 11.869M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 27.00 |
| 2023-08-04 | JMP Securities | Roy Buchanan | Maintains | OutperformOutperform | Raises | 24.00 | 25.00 |
| 2023-05-03 | JMP Securities | Roy Buchanan | Maintains | Outperform | Lowers | 25.00 | 24.00 |
| 2023-05-03 | HC Wainwright & Co. | Edward White | Reiterates | Buy | Maintains | - | 27.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| DVAX | Dynavax Technologies | -0.66% | 1.8B |
| IDYA | IDEAYA Biosciences | -1.99% | 1.6B |
| RARE | Ultragenyx Pharmaceutical | -0.49% | 2.6B |
| ZNTL | Zentalis Pharma | -3.93% | 1.5B |
| MRTX | Mirati Therapeutics | 12.33% | 2.9B |
How do I buy Dynavax Technologies (DVAX) stock?
You can purchase shares of Dynavax Technologies (NASDAQ: DVAX) through any online brokerage.
Who are Dynavax Technologies's (DVAX) competitors?
Other companies in Dynavax Technologies’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Zentalis Pharma (NASDAQ:ZNTL), Mirati Therapeutics (NASDAQ:MRTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on Friday, August 4, 2023. The analyst firm set a price target for 27.00 expecting DVAX to rise to within 12 months (a possible 97.95% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Dynavax Technologies (DVAX)?
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $13.64 last updated September 22, 2023 at 8:00 PM UTC.
Does Dynavax Technologies (DVAX) pay a dividend?
There is no dividend information for Dynavax Technologies.
When is Dynavax Technologies (NASDAQ:DVAX) reporting earnings?
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Dynavax Technologies (DVAX) going to split?
There is no upcoming split for Dynavax Technologies.
What sector and industry does Dynavax Technologies (DVAX) operate in?
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.